Software - Application
Compare Stocks
5 / 10Stock Comparison
PCOR vs ROP vs CSGP vs VEEV vs VRSK
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Real Estate - Services
Medical - Healthcare Information Services
Consulting Services
PCOR vs ROP vs CSGP vs VEEV vs VRSK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Industrial - Machinery | Real Estate - Services | Medical - Healthcare Information Services | Consulting Services |
| Market Cap | $8.04B | $35.34B | $13.89B | $27.03B | $22.52B |
| Revenue (TTM) | $1.37B | $8.12B | $3.41B | $3.20B | $3.10B |
| Net Income (TTM) | $-77M | $1.71B | $25M | $909M | $910M |
| Gross Margin | 79.6% | 69.4% | 77.4% | 75.5% | 67.4% |
| Operating Margin | -7.1% | 28.1% | -0.8% | 28.7% | 44.9% |
| Forward P/E | 31.7x | 15.7x | 24.1x | 18.8x | 22.5x |
| Total Debt | $118M | $9.30B | $1.14B | $96M | $5.04B |
| Cash & Equiv. | $481M | $297M | $1.73B | $1.42B | $2.18B |
PCOR vs ROP vs CSGP vs VEEV vs VRSK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 21 | May 26 | Return |
|---|---|---|---|
| Procore Technologie… (PCOR) | 100 | 61.7 | -38.3% |
| Roper Technologies,… (ROP) | 100 | 76.3 | -23.7% |
| CoStar Group, Inc. (CSGP) | 100 | 38.4 | -61.6% |
| Veeva Systems Inc. (VEEV) | 100 | 57.1 | -42.9% |
| Verisk Analytics, I… (VRSK) | 100 | 99.4 | -0.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PCOR vs ROP vs CSGP vs VEEV vs VRSK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PCOR ranks third and is worth considering specifically for momentum.
- -19.8% vs CSGP's -56.8%
ROP is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 12 yrs, beta 0.39, yield 1.0%
- Beta 0.39, yield 1.0%, current ratio 0.52x
- Lower P/E (15.7x vs 22.5x), PEG 1.63 vs 2.63
- Beta 0.39 vs PCOR's 1.27
CSGP is the clearest fit if your priority is growth.
- 18.7% FFO/revenue growth vs VRSK's 6.6%
VEEV is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 16.3%, EPS growth 25.9%, 3Y rev CAGR 14.0%
- Lower volatility, beta 0.72, Low D/E 1.3%, current ratio 4.89x
- PEG 1.03 vs VRSK's 2.63
VRSK carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 133.5% 10Y total return vs VEEV's 5.1%
- 29.3% margin vs PCOR's -5.6%
- 1.1% yield, 7-year raise streak, vs ROP's 1.0%, (3 stocks pay no dividend)
- 16.7% ROA vs PCOR's -3.7%, ROIC 33.0% vs -9.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.7% FFO/revenue growth vs VRSK's 6.6% | |
| Value | Lower P/E (15.7x vs 22.5x), PEG 1.63 vs 2.63 | |
| Quality / Margins | 29.3% margin vs PCOR's -5.6% | |
| Stability / Safety | Beta 0.39 vs PCOR's 1.27 | |
| Dividends | 1.1% yield, 7-year raise streak, vs ROP's 1.0%, (3 stocks pay no dividend) | |
| Momentum (1Y) | -19.8% vs CSGP's -56.8% | |
| Efficiency (ROA) | 16.7% ROA vs PCOR's -3.7%, ROIC 33.0% vs -9.7% |
PCOR vs ROP vs CSGP vs VEEV vs VRSK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
PCOR vs ROP vs CSGP vs VEEV vs VRSK — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ROP leads in 1 of 6 categories
VRSK leads 1 • PCOR leads 1 • CSGP leads 0 • VEEV leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — CSGP and VRSK each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ROP is the larger business by revenue, generating $8.1B annually — 5.9x PCOR's $1.4B. VRSK is the more profitable business, keeping 29.3% of every revenue dollar as net income compared to PCOR's -5.6%. On growth, CSGP holds the edge at +22.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.4B | $8.1B | $3.4B | $3.2B | $3.1B |
| EBITDAEarnings before interest/tax | $16M | $3.2B | $278M | $956M | $1.7B |
| Net IncomeAfter-tax profit | -$77M | $1.7B | $25M | $909M | $910M |
| Free Cash FlowCash after capex | $275M | $2.6B | $241M | $1.4B | $1.1B |
| Gross MarginGross profit ÷ Revenue | +79.6% | +69.4% | +77.4% | +75.5% | +67.4% |
| Operating MarginEBIT ÷ Revenue | -7.1% | +28.1% | -0.8% | +28.7% | +44.9% |
| Net MarginNet income ÷ Revenue | -5.6% | +21.1% | +0.7% | +28.4% | +29.3% |
| FCF MarginFCF ÷ Revenue | +20.0% | +31.4% | +7.1% | +43.7% | +36.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.7% | +11.3% | +22.5% | +16.0% | +3.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +72.7% | +59.1% | +127.7% | +23.9% | +4.8% |
Valuation Metrics
ROP leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 24.2x trailing earnings, ROP trades at a 99% valuation discount to CSGP's 1974.1x P/E. Adjusting for growth (PEG ratio), VEEV offers better value at 1.68x vs VRSK's 3.10x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $8.0B | $35.3B | $13.9B | $27.0B | $22.5B |
| Enterprise ValueMkt cap + debt − cash | $7.7B | $44.3B | $13.3B | $25.7B | $25.4B |
| Trailing P/EPrice ÷ TTM EPS | -79.52x | 24.18x | 1974.10x | 30.56x | 26.48x |
| Forward P/EPrice ÷ next-FY EPS est. | 31.68x | 15.66x | 24.05x | 18.76x | 22.47x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.52x | — | 1.68x | 3.10x |
| EV / EBITDAEnterprise value multiple | — | 14.27x | 78.23x | 28.05x | 15.12x |
| Price / SalesMarket cap ÷ Revenue | 6.08x | 4.47x | 4.28x | 8.46x | 7.33x |
| Price / BookPrice ÷ Book value/share | 6.34x | 1.86x | 1.65x | 3.85x | 77.18x |
| Price / FCFMarket cap ÷ FCF | 37.35x | 14.18x | 338.75x | 19.10x | 18.89x |
Profitability & Efficiency
VRSK leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
VRSK delivers a 4.4% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $-6 for PCOR. VEEV carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRSK's 16.26x. On the Piotroski fundamental quality scale (0–9), ROP scores 6/9 vs PCOR's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -6.3% | +8.8% | +0.3% | +13.4% | +4.4% |
| ROA (TTM)Return on assets | -3.7% | +5.0% | +0.2% | +11.1% | +16.7% |
| ROICReturn on invested capital | -9.7% | +6.1% | -0.9% | +12.9% | +33.0% |
| ROCEReturn on capital employed | -8.6% | +7.7% | -0.8% | +13.8% | +39.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 5 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.09x | 0.47x | 0.14x | 0.01x | 16.26x |
| Net DebtTotal debt minus cash | -$362M | $9.0B | -$589M | -$1.3B | $2.9B |
| Cash & Equiv.Liquid assets | $481M | $297M | $1.7B | $1.4B | $2.2B |
| Total DebtShort + long-term debt | $118M | $9.3B | $1.1B | $96M | $5.0B |
| Interest CoverageEBIT ÷ Interest expense | -43.00x | 6.50x | 1.58x | — | 7.87x |
Total Returns (Dividends Reinvested)
PCOR leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in VRSK five years ago would be worth $9,980 today (with dividends reinvested), compared to $3,903 for CSGP. Over the past 12 months, PCOR leads with a -19.8% total return vs CSGP's -56.8%. The 3-year compound annual growth rate (CAGR) favors PCOR at -1.3% vs CSGP's -23.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -23.9% | -20.6% | -50.1% | -24.3% | -22.0% |
| 1-Year ReturnPast 12 months | -19.8% | -39.7% | -56.8% | -30.6% | -43.6% |
| 3-Year ReturnCumulative with dividends | -3.8% | -23.0% | -55.9% | -6.3% | -15.9% |
| 5-Year ReturnCumulative with dividends | -39.5% | -19.5% | -61.0% | -33.3% | -0.2% |
| 10-Year ReturnCumulative with dividends | -39.5% | +109.8% | +66.3% | +512.1% | +133.5% |
| CAGR (3Y)Annualised 3-year return | -1.3% | -8.3% | -23.9% | -2.2% | -5.6% |
Risk & Volatility
Evenly matched — PCOR and VRSK each lead in 1 of 2 comparable metrics.
Risk & Volatility
VRSK is the less volatile stock with a -0.08 beta — it tends to amplify market swings less than PCOR's 1.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PCOR currently trades 64.7% from its 52-week high vs CSGP's 33.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.27x | 0.39x | 0.69x | 0.72x | -0.08x |
| 52-Week HighHighest price in past year | $82.32 | $584.03 | $97.43 | $310.50 | $322.92 |
| 52-Week LowLowest price in past year | $46.08 | $313.86 | $32.71 | $148.05 | $161.70 |
| % of 52W HighCurrent price vs 52-week peak | +64.7% | +58.8% | +33.6% | +53.5% | +53.2% |
| RSI (14)Momentum oscillator 0–100 | 45.7 | 46.3 | 36.3 | 50.6 | 43.9 |
| Avg Volume (50D)Average daily shares traded | 2.1M | 1.2M | 5.9M | 2.3M | 1.9M |
Analyst Outlook
Evenly matched — ROP and VRSK each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PCOR as "Buy", ROP as "Buy", CSGP as "Buy", VEEV as "Buy", VRSK as "Hold". Consensus price targets imply 86.7% upside for CSGP (target: $61) vs 26.5% for PCOR (target: $67). For income investors, VRSK offers the higher dividend yield at 1.05% vs ROP's 0.96%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $67.40 | $457.64 | $61.18 | $280.10 | $231.25 |
| # AnalystsCovering analysts | 24 | 23 | 25 | 42 | 25 |
| Dividend YieldAnnual dividend ÷ price | — | +1.0% | — | — | +1.1% |
| Dividend StreakConsecutive years of raises | — | 12 | — | — | 7 |
| Dividend / ShareAnnual DPS | — | $3.29 | — | — | $1.81 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.6% | +1.4% | +4.1% | +0.6% | +2.8% |
ROP leads in 1 of 6 categories (Valuation Metrics). VRSK leads in 1 (Profitability & Efficiency). 3 tied.
PCOR vs ROP vs CSGP vs VEEV vs VRSK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PCOR or ROP or CSGP or VEEV or VRSK a better buy right now?
For growth investors, CoStar Group, Inc.
(CSGP) is the stronger pick with 18. 7% revenue growth year-over-year, versus 6. 6% for Verisk Analytics, Inc. (VRSK). Roper Technologies, Inc. (ROP) offers the better valuation at 24. 2x trailing P/E (15. 7x forward), making it the more compelling value choice. Analysts rate Procore Technologies, Inc. (PCOR) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PCOR or ROP or CSGP or VEEV or VRSK?
On trailing P/E, Roper Technologies, Inc.
(ROP) is the cheapest at 24. 2x versus CoStar Group, Inc. at 1974. 1x. On forward P/E, Roper Technologies, Inc. is actually cheaper at 15. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Veeva Systems Inc. wins at 1. 03x versus Verisk Analytics, Inc. 's 2. 63x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — PCOR or ROP or CSGP or VEEV or VRSK?
Over the past 5 years, Verisk Analytics, Inc.
(VRSK) delivered a total return of -0. 2%, compared to -61. 0% for CoStar Group, Inc. (CSGP). Over 10 years, the gap is even starker: VEEV returned +512. 1% versus PCOR's -39. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PCOR or ROP or CSGP or VEEV or VRSK?
By beta (market sensitivity over 5 years), Verisk Analytics, Inc.
(VRSK) is the lower-risk stock at -0. 08β versus Procore Technologies, Inc. 's 1. 27β — meaning PCOR is approximately -1606% more volatile than VRSK relative to the S&P 500. On balance sheet safety, Veeva Systems Inc. (VEEV) carries a lower debt/equity ratio of 1% versus 16% for Verisk Analytics, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — PCOR or ROP or CSGP or VEEV or VRSK?
By revenue growth (latest reported year), CoStar Group, Inc.
(CSGP) is pulling ahead at 18. 7% versus 6. 6% for Verisk Analytics, Inc. (VRSK). On earnings-per-share growth, the picture is similar: Veeva Systems Inc. grew EPS 25. 9% year-over-year, compared to -95. 1% for CoStar Group, Inc.. Over a 3-year CAGR, PCOR leads at 22. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PCOR or ROP or CSGP or VEEV or VRSK?
Verisk Analytics, Inc.
(VRSK) is the more profitable company, earning 29. 6% net margin versus -7. 6% for Procore Technologies, Inc. — meaning it keeps 29. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VRSK leads at 44. 6% versus -8. 9% for PCOR. At the gross margin level — before operating expenses — PCOR leads at 78. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PCOR or ROP or CSGP or VEEV or VRSK more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Veeva Systems Inc. (VEEV) is the more undervalued stock at a PEG of 1. 03x versus Verisk Analytics, Inc. 's 2. 63x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Roper Technologies, Inc. (ROP) trades at 15. 7x forward P/E versus 31. 7x for Procore Technologies, Inc. — 16. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CSGP: 86. 7% to $61. 18.
08Which pays a better dividend — PCOR or ROP or CSGP or VEEV or VRSK?
In this comparison, VRSK (1.
1% yield), ROP (1. 0% yield) pay a dividend. PCOR, CSGP, VEEV do not pay a meaningful dividend and should not be held primarily for income.
09Is PCOR or ROP or CSGP or VEEV or VRSK better for a retirement portfolio?
For long-horizon retirement investors, Verisk Analytics, Inc.
(VRSK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 1. 1% yield, +133. 5% 10Y return). Both have compounded well over 10 years (VRSK: +133. 5%, PCOR: -39. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PCOR and ROP and CSGP and VEEV and VRSK?
These companies operate in different sectors (PCOR (Technology) and ROP (Industrials) and CSGP (Real Estate) and VEEV (Healthcare) and VRSK (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: PCOR is a small-cap quality compounder stock; ROP is a mid-cap quality compounder stock; CSGP is a mid-cap high-growth stock; VEEV is a mid-cap high-growth stock; VRSK is a mid-cap quality compounder stock. ROP, VRSK pay a dividend while PCOR, CSGP, VEEV do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.